Fatima Kranc
Business Development Manager
Cancer Research TechnologyUnited Kingdom
13 investmentsFatima Kranc is a Business Development Manager at Cancer Research Technology based in United Kingdom. Fatima Kranc has backed 13 companies, including Nu Quantum, Colorifix and Nyobolt. Investment focus areas include Health Care, Commercial and Telecommunications.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Health Care
Commercial
Telecommunications
Cybersecurity
Investment Management
Network Hardware
Life Science
Education
Artificial Intelligence (AI)
Information Technology (IT)
Marketplace
Software
Biotechnology
Fashion
Teaching STEM Concepts
Market Research
FinTech
B2C
Hardware
Renewable Energy
Medical
Battery
Sensors
Advanced Materials
Machine Learning
Pharmaceuticals
Portfolio Companies (13)
| 1 | Nu Quantum |
| 2 | Colorifix |
| 3 | Nyobolt |
| 4 | Abselion |
| 5 | Bond180 |
| 6 | Evoralis |
| 7 | Cambridge GaN Devices |
| 8 | PharmEnable |
| 9 | Sano Genetics |
| 10 | Semarion |
| 11 | Colorifix Limited |
| 12 | CamRegen Limited |
Showing 1–12 of 13
Page 1 of 2
Access Full Contact Information
Get Fatima Kranc's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
3-day free trial, cancel anytime
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.